We are live on
!
Find out more
Korea Investment Corp Portfolio holdings
AUM
$48.3B
1-Year Est. Return
31.57%
This Fund
S&P 500
This Quarter
Est. Return
+7.46%
1 Year Est. Return
+31.57%
3 Year Est. Return
+108.38%
5 Year Est. Return
+144.09%
10 Year Est. Return
+570.78%
AUM
$20.2B
AUM Growth
-$647M
(-3.1%)
Cap. Flow
-$1.93B
Cap. Flow
% of AUM
-9.55%
Top 10 Holdings %
Top 10 Hldgs %
27.3%
Holding
675
New
55
Increased
260
Reduced
318
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$71.2M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$46.8M |
| 3 |
Amgen
AMGN
|
+$40.4M |
| 4 |
Philip Morris
PM
|
+$37.4M |
| 5 |
ConocoPhillips
COP
|
+$34.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$207M |
| 2 |
Pfizer
PFE
|
+$62.5M |
| 3 |
Wells Fargo
WFC
|
+$62.3M |
| 4 |
Newell Brands
NWL
|
+$54.3M |
| 5 |
Microsoft
MSFT
|
+$53.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.21% |
| 2 | Technology | 13.93% |
| 3 | Healthcare | 10.33% |
| 4 | Communication Services | 9.31% |
| 5 | Consumer Discretionary | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
A.O. Smith
AOS
$8.7B
| $102K | ﹤0.01% |
+2,000
| New | +$99.2K |
|
602
VF Corp
VFC
$5.89B
| $70K | ﹤0.01% |
1,353
+937
| +225% | +$46.2K |
|
603
Molson Coors Class B
TAP
$8.09B
| $69K | ﹤0.01% |
723
+501
| +226% | +$48.9K |
|
604
Viatris
VTRS
$18.9B
| $68K | ﹤0.01% |
1,745
+1,208
| +225% | +$48.7K |
|
605
Newmont
NEM
$119B
| $67K | ﹤0.01% |
2,036
-232,890
| -99% | -$8.13M |
|
606
Autodesk
ADSK
$52.6B
| $66K | ﹤0.01% |
767
+531
| +225% | +$44.4K |
|
607
Equifax
EFX
$21.4B
| $63K | ﹤0.01% |
458
+317
| +225% | +$40.3K |
|
608
Mercado Libre
MELI
$92.3B
| $63K | ﹤0.01% |
+300
| New | +$58.7K |
|
|
MJN
609
DELISTED
Mead Johnson Nutrition Company
MJN
| $63K | ﹤0.01% |
708
-21,210
| -97% | -$1.74M |
|
610
Vulcan Materials
VMC
$36.9B
| $62K | ﹤0.01% |
511
+354
| +225% | +$43.3K |
|
611
Expedia Group
EXPE
$37.3B
| $60K | ﹤0.01% |
473
+327
| +224% | +$39.9K |
|
612
Realty Income
O
$59.1B
| $59K | ﹤0.01% |
1,024
-50,478
| -98% | -$2.92M |
|
613
NOV
NOV
$7B
| $58K | ﹤0.01% |
1,449
+1,003
| +225% | +$39.1K |
|
614
BioMarin Pharmaceuticals
BMRN
$12.4B
| $57K | ﹤0.01% |
655
+453
| +224% | +$40.3K |
|
615
Healthpeak Properties
DOC
$14.8B
| $56K | ﹤0.01% |
1,794
-163,358
| -99% | -$5.02M |
|
616
Dentsply Sirona
XRAY
$2.43B
| $56K | ﹤0.01% |
894
+619
| +225% | +$37.3K |
|
|
HES
617
DELISTED
Hess
HES
| $53K | ﹤0.01% |
1,093
+757
| +225% | +$40.1K |
|
618
Markel Group
MKL
$23.2B
| $53K | ﹤0.01% |
54
+37
| +218% | +$35K |
|
619
Chipotle Mexican Grill
CMG
$41.5B
| $50K | ﹤0.01% |
5,600
+3,900
| +229% | +$32.2K |
|
620
Ametek
AME
$58.2B
| $48K | ﹤0.01% |
892
+618
| +226% | +$32.6K |
|
621
CMS Energy
CMS
$22.3B
| $48K | ﹤0.01% |
1,074
+744
| +225% | +$32.2K |
|
622
Ball Corp
BALL
$16.8B
| $47K | ﹤0.01% |
1,270
+880
| +226% | +$32.8K |
|
623
IQVIA
IQV
$39.3B
| $45K | ﹤0.01% |
565
-123,858
| -100% | -$9.67M |
|
624
TransDigm Group
TDG
$67.7B
| $45K | ﹤0.01% |
204
-25,046
| -99% | -$5.98M |
|
625
CarMax
KMX
$8.26B
| $44K | ﹤0.01% |
735
+509
| +225% | +$33.1K |
|
Similar funds
TI
RIM
LP
Korea Investment Corp's Q1 2017 Portfolio in Review
As of Q1 2017, Korea Investment Corp held 675 positions worth $20.2B, down 3.1% from $20.8B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Korea Investment Corp withdrew a net $1.93B in Q1 2017, closing 32 positions and reducing 318 holdings. Its most notable exit was Merck, an estimated $207M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Korea Investment Corp opened a new position in Wynn Resorts worth $31.8M.
- Korea Investment Corp's largest Q1 2017 buy was Wynn Resorts: 277,800 shares worth $31.8M.
- Korea Investment Corp added most to Johnson & Johnson in Q1 2017, an estimated $71.2M increase.
- Korea Investment Corp's biggest Q1 2017 reduction was Pfizer, cutting an estimated $62.5M.
- Korea Investment Corp fully exited Merck in Q1 2017, selling an estimated $207M.
- Korea Investment Corp's ten largest holdings make up 27% of its $20.2B portfolio in Q1 2017.
- Korea Investment Corp opened 55 new positions and closed 32 in Q1 2017.
- Korea Investment Corp's portfolio value fell 3.1% quarter-over-quarter to $20.2B.
Based on Korea Investment Corp's 13F filing for Q1 2017, filed 25 Apr 2017.